NO914217L - Sakkarinderivater nyttige som proteolytiske enzyminhibitorer og fremstilling derav - Google Patents

Sakkarinderivater nyttige som proteolytiske enzyminhibitorer og fremstilling derav

Info

Publication number
NO914217L
NO914217L NO91914217A NO914217A NO914217L NO 914217 L NO914217 L NO 914217L NO 91914217 A NO91914217 A NO 91914217A NO 914217 A NO914217 A NO 914217A NO 914217 L NO914217 L NO 914217L
Authority
NO
Norway
Prior art keywords
inhibitors
proteolytic
enzymin
manufacturing
derivatives used
Prior art date
Application number
NO91914217A
Other languages
English (en)
Other versions
NO300808B1 (no
NO914217D0 (no
Inventor
Richard Paul Dunlap
Neil Warren Boaz
Albert Joseph Mura
Dennis John Hlasta
Original Assignee
Sterling Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Winthrop Inc filed Critical Sterling Winthrop Inc
Publication of NO914217L publication Critical patent/NO914217L/no
Publication of NO914217D0 publication Critical patent/NO914217D0/no
Publication of NO300808B1 publication Critical patent/NO300808B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrrole Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
NO914217A 1989-05-04 1991-10-28 Analogifremgangsmåte for fremstilling av farmasöytisk virksomme sakkarinderivater nyttige som proteolytiske enzyminhibitorer NO300808B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34712589A 1989-05-04 1989-05-04
US34712689A 1989-05-04 1989-05-04
PCT/US1990/002434 WO1990013549A1 (en) 1989-05-04 1990-05-01 Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof

Publications (3)

Publication Number Publication Date
NO914217L true NO914217L (no) 1991-10-28
NO914217D0 NO914217D0 (no) 1991-10-28
NO300808B1 NO300808B1 (no) 1997-07-28

Family

ID=26995139

Family Applications (1)

Application Number Title Priority Date Filing Date
NO914217A NO300808B1 (no) 1989-05-04 1991-10-28 Analogifremgangsmåte for fremstilling av farmasöytisk virksomme sakkarinderivater nyttige som proteolytiske enzyminhibitorer

Country Status (17)

Country Link
EP (1) EP0471756B1 (no)
JP (1) JPH04507095A (no)
KR (1) KR0183397B1 (no)
AT (1) ATE159720T1 (no)
AU (1) AU637614B2 (no)
DE (1) DE69031656T2 (no)
DK (1) DK0471756T3 (no)
ES (1) ES2110414T3 (no)
FI (1) FI103111B (no)
GR (1) GR1000965B (no)
IL (1) IL94278A (no)
MY (1) MY106202A (no)
NO (1) NO300808B1 (no)
NZ (1) NZ233521A (no)
PT (1) PT93959B (no)
SG (1) SG48298A1 (no)
WO (1) WO1990013549A1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204261B1 (en) 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
US6008217A (en) * 1995-12-20 1999-12-28 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β converting enzyme
US5874424A (en) * 1995-12-20 1999-02-23 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β converting enzyme
US5236917A (en) * 1989-05-04 1993-08-17 Sterling Winthrop Inc. Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5380737A (en) * 1989-05-04 1995-01-10 Sterling Winthrop Inc. Saccharin derivative proteolytic enzyme inhibitors
AU642537B2 (en) * 1990-11-01 1993-10-21 Sanofi 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5250696A (en) * 1990-11-01 1993-10-05 Sterling Winthrop Inc. 2-saccharinylmethyl aryl carboxylate
US5512589A (en) * 1990-11-01 1996-04-30 Sterling Winthrop Inc. 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5306818A (en) * 1990-11-01 1994-04-26 Sterling Winthrop Inc. Tetrahydro 2-saccharinylmerthyl aryl carboxylates
AU656027B2 (en) * 1991-11-15 1995-01-19 Sanofi Saccharin derivative proteolytic enzime inhibitors
AU668694B2 (en) * 1991-12-19 1996-05-16 Sanofi-Synthelabo Saccharin derivative proteolytic enzyme inhibitors
US5378720A (en) * 1991-12-19 1995-01-03 Sterling Winthrop Inc. Saccharin derivative proteolytic enzyme inhibitors
US5187173A (en) * 1991-12-27 1993-02-16 Sterling Winthrop Inc. 2-saccharinylmethyl and 4,5,6,7-tetrahydro-2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5296496A (en) * 1991-12-27 1994-03-22 Sterling Winthrop Inc. 2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
TW226016B (no) * 1991-12-30 1994-07-01 Sterling Winthrop Inc
AU653279B2 (en) * 1991-12-30 1994-09-22 Sanofi Novel 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
DE4413951C1 (de) * 1994-04-21 1995-08-03 Cpc Maizena Gmbh Verfahren zur Herstellung einer Würzsoße
US6420522B1 (en) 1995-06-05 2002-07-16 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β converting enzyme
US5684195A (en) * 1994-07-14 1997-11-04 G. D. Searle & Co. Method of preparing sulfmonamides from sulfones
DE4427996A1 (de) * 1994-08-08 1996-02-15 Basf Ag Verfahren zur Herstellung von Saccharincarbonsäuren und -carbonsäureestern
US5494925A (en) * 1994-12-02 1996-02-27 Sterling Winthrop Inc. 2-heterocyclyloxymethyl and 2-heterocyclylthiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
US5843904A (en) * 1995-12-20 1998-12-01 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1βconverting enzyme
CA2702950A1 (en) * 2007-10-16 2009-04-23 Northeastern University Methods and compounds for modulating cannabinoid activity

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1302858B (no) * 1962-09-21 1972-05-04
JPS47419B1 (no) * 1969-12-22 1972-01-07
US4195023A (en) * 1975-08-20 1980-03-25 Merck & Co., Inc. 2-(2-Furoyl)1,2-benzisothiazole-3-one, 2-(2-furoyl) saccharin, and 2-(2-thenoyl) saccharin
DE2800019A1 (de) * 1978-01-02 1979-07-12 Dynamit Nobel Ag N-halobenzyl-saccharine, ihre herstellung und verwendung
US4276298A (en) * 1978-03-24 1981-06-30 Merck & Co., Inc. 2-Aryl-1,2-benzisothiazolinone-1,1-dioxides and their use as selective protease inhibitors
US4350752A (en) * 1980-12-29 1982-09-21 Eastman Kodak Company Photographic elements and film units containing imidomethyl blocked photographic reagents
US4410618A (en) * 1982-06-11 1983-10-18 Eastman Kodak Company Blocked photographic reagents
CS241932B1 (cs) * 1984-05-25 1986-04-17 Jiri Svoboda Způsob výroby substituovaných benzisothiazolin- -3-on-l,1-dioxidů
US4748182A (en) * 1986-03-05 1988-05-31 Merrell Dow Pharmaceuticals Inc. Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives and their use as anti-hypertensive and anxiolytic agents
AU642537B2 (en) * 1990-11-01 1993-10-21 Sanofi 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
JPH07200419A (ja) * 1993-12-28 1995-08-04 Nec Corp バスインタフェース装置

Also Published As

Publication number Publication date
EP0471756A4 (en) 1992-04-08
GR1000965B (el) 1993-03-16
KR0183397B1 (ko) 1999-05-01
NO300808B1 (no) 1997-07-28
IL94278A (en) 1995-03-30
MY106202A (en) 1995-03-31
PT93959A (pt) 1991-01-08
FI103111B1 (fi) 1999-04-30
DE69031656T2 (de) 1998-04-09
PT93959B (pt) 1996-11-29
GR900100326A (en) 1991-10-10
AU637614B2 (en) 1993-06-03
EP0471756A1 (en) 1992-02-26
JPH04507095A (ja) 1992-12-10
FI915093A0 (fi) 1991-10-29
ES2110414T3 (es) 1998-02-16
NO914217D0 (no) 1991-10-28
WO1990013549A1 (en) 1990-11-15
IL94278A0 (en) 1991-03-10
KR920701203A (ko) 1992-08-11
DK0471756T3 (da) 1998-05-18
ATE159720T1 (de) 1997-11-15
DE69031656D1 (de) 1997-12-04
EP0471756B1 (en) 1997-10-29
AU5664990A (en) 1990-11-29
FI103111B (fi) 1999-04-30
SG48298A1 (en) 1998-04-17
NZ233521A (en) 1992-05-26

Similar Documents

Publication Publication Date Title
NO914217D0 (no) Sakkarinderivater nyttige som proteolytiske enzyminhibitorer og fremstilling derav
NO941937D0 (no) Sakarinderivater som inhiberer proteolytiske enzymer
NO881697D0 (no) Verktoeyenhet, verktoeydeler og fremgangsmaate for sammensetting av delene.
FI925787A0 (fi) Proteolytiska enzymers sackarinderivatinhibitorer
SE8602723D0 (sv) Thiazoles, their production and pharmaceutical compositions containing them
NO972391D0 (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
DK585984D0 (da) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan og salte deraf til anvendelse ved bekaempelse af sygdomme samt fremgangsmaade til fremstilling af saadanne nonanderivater
BG44708A3 (bg) Метод за получаване на спиро-3-хетероазолони
NO904335D0 (no) Fenylsulfon-derivater.
DK688087D0 (da) Imidazolderivater, fremgangsmaade til fremstilling deraf og anvendelse deraf som antimycotiske midler
ES2082212T3 (es) Nuevos inhibidores de alfa-glucosidasa.
FI890864A0 (fi) Anvaendning av 1,4-dihydropyridinderivat.
NO871477D0 (no) Fremgangsmaate for fremstilling av human plasminogenaktivator.
DK275784D0 (da) 6-(aminomethyl)penicillansyre-1,1-dioxid-estere, som er hydrolyserbare under fysiologiske betingelser, og aminobeskyttede 6-(aminomethyl)penicillansyre-forbindelser til anvendelse som mellemprodukter herfor
DK47988A (da) Substituerede 3-phenyl-7h-thiazolooe3,2-baaoe1,2,4aatriazin-7-oner, deres fremstilling og anvendelse som laegemiddel, samt ved fremstillingen anvendelige mellemprodukter
ATE75938T1 (de) Enantiomere des propafenons enthaltende therapeutische mittel.
NO883987D0 (no) Fremgangsmaate for fremstilling av n-(substituert aklyliden) kondensert bicykloalkyliden og anvendelse derav som medikamenter.
FR2604704B1 (fr) Derives de 4-phenylthiazole, procede de preparation et utilisation en therapeutique
NO903956D0 (no) Sammensetninger som inneholder thymopentin til topisk behandling av hudsykdommer.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN NOVEMBER 2000